Study Conduct

Novartis, Janssen, Eli Lilly, Aptiv Solutions co-found new consortium

Friday, February 21, 2014 11:05 AM

Aptiv Solutions, a global biopharmaceutical and medical device development services company, Novartis Pharma, Janssen Pharmaceuticals and Eli Lilly have joined in co-founding the ADDPLAN DF Consortium. The members of the consortium are collaboratively developing new statistical methodologies for the design of innovative dose-finding clinical trials, with an emphasis on adaptive designs. The ADDPLAN DF Consortium also will focus on enhancing the trial execution technologies required to handle the multiple adaptations integral to complex adaptive dose-finding trials. Aptiv Solutions will integrate and validate the methodologies that emerge from the ADDPLAN DF Consortium into its ADDPLAN DF software for the design, planning and analysis of dose finding trials, in addition to ensuring that these designs can be easily implemented through its proprietary execution platform.

More... »

WIRB Copernicus Group

NHS England responds to concerns about information sharing

Wednesday, February 19, 2014 01:11 PM

Tim Kelsey, national director for patients and information for NHS England, has issued a statement in response to concerns about information sharing, saying, In recent weeks, we have heard from patients, many GPs, their professional organizations and groups like Healthwatch. They have told us very clearly that patients need more time to learn about information sharing, the benefits and their right to object.”

More... »


Sir Stuart Rose to advise on NHS leadership

Friday, February 14, 2014 01:49 PM

Sir Stuart Rose, a highly-regarded business leader in Britain who turned around the fortunes of Marks and Spencer, will advise how the NHS can attract and retain the very best leaders to help transform the culture in under-performing hospitals.

More... »

Drugs.com, TrialReach to give patients access to drugs in development

Thursday, February 13, 2014 02:48 PM

Drugs.com, an online clinical drug resource, and TrialReachare partnering to provide patients with information and access to treatments that are still under development. The new partnership will bring TrialReach's patient-centric content and tools directly to the 25 million people who visit Drugs.com every month.

More... »

Parexel rebrands technology subsidiary as Parexel Informatics

Thursday, February 13, 2014 02:06 PM

Global CRO Parexel International has rebranded its Perceptive Informatics subsidiary, which provides the Perceptive MyTrials eClinical platform and other advanced clinical development technology solutions, as Parexel Informatics.

More... »

GSK, Uppsala launch $140.6M European program targeting novel antibiotics

Wednesday, February 12, 2014 01:20 PM

Over 30 European universities, research institutes and companies, led by GlaxoSmithKline and Uppsala University, are joining forces in a six-year program supported by the Innovative Medicines Initiative (IMI) to develop novel antibiotics against Gram-negative pathogens in a project called ENABLE (European Gram-Negative Antibacterial Engine), including open calls for candidates outside the consortium.

More... »

Ulster launches a clinical research network for mental health

Thursday, February 6, 2014 11:47 AM

The University of Ulsterhas launched a dedicated Clinical Research Network for Northern Ireland. The new network means that mental health patients from Northern Ireland can now be involved in major national and international research trials. It also will ensure researchers and health professionals have a better understanding of mental health services.  

More... »

Boston Children's Hospital partners on pharmacogenomics study in pediatric population

Wednesday, February 5, 2014 01:36 PM

Aiming to reduce adverse drug reactions—which affect some 70,000 children annually in the U.S.—a study at Boston Children's Hospital, in partnership with the Medical College of Wisconsin(MCW) and the Children's Hospital of Wisconsin Research Institute, is using genetic information to predict children's reactions to medications, ultimately enabling clinicians to select a more individualized therapy for the patient.

More... »

Local dementia experts visit Russia to share best practices in phase III Alzheimer's study

Wednesday, February 5, 2014 01:29 PM

A doctor-and-nurse team from the Neurological Associates of Albanyclinic will travel to St. Petersburg, Russia, next month to meet with clinical research doctors about TauRx Therapeutics' global phase III clinical trial for mild to moderate Alzheimer's disease. They are invited guests to help share their experience in conducting this study with their Russian counterparts in preparation for the study's launch in Russia.

More... »

NIH grants $1.48M for Massachusetts patient medication adherence study

Wednesday, February 5, 2014 01:21 PM

University of Arizona (UA) associate professor of anthropology Susan J. Shaw and UA assistant professor of pharmacy Jeannie Lee have received $1.48 million from the NIH to study factors that affect medication adherence among residents in Massachusetts, where state law mandates that nearly every resident receive a minimum level of healthcare insurance coverage.

More... »

Subscribe to The CenterWatch Monthly
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

August 18

Ebola outbreak highlights need to improve biosafety, infrastructure to handle future health emergencies

More African American professional women open to participating in medical research

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs